David D. McMasters
Corporate Officer/Principal at Washington State Bar Association
Profile
David D.
McMasters is a Member of the Washington State Bar Association.
He was previously the Chief Executive Officer & Managing Director at Seed & Berry LLP.
From 2000 to 2011, he served as the Senior Vice President-Legal & General Counsel at Angiotech Pharmaceuticals, Inc. From 2012 to 2020, he was the General Counsel at Correvio Pharma Corp.
McMasters has an undergraduate degree from the University of Washington and a graduate degree from Northwestern University.
David D. McMasters active positions
Companies | Position | Start |
---|---|---|
Washington State Bar Association
Washington State Bar Association Miscellaneous Commercial ServicesCommercial Services The Washington State Bar Association operates the state bar association. | Corporate Officer/Principal | 24/03/2009 |
Former positions of David D. McMasters
Companies | Position | End |
---|---|---|
CORREVIO PHARMA CORP. | General Counsel | 26/05/2020 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | General Counsel | 13/07/2011 |
Seed & Berry LLP | President | - |
Training of David D. McMasters
University of Washington | Undergraduate Degree |
Northwestern University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Seed & Berry LLP | |
Washington State Bar Association
Washington State Bar Association Miscellaneous Commercial ServicesCommercial Services The Washington State Bar Association operates the state bar association. | Commercial Services |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |
Correvio Pharma Corp.
Correvio Pharma Corp. Pharmaceuticals: MajorHealth Technology Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients and healthcare systems. The company was founded in 1986 and is headquartered in Vancouver, Canada. | Health Technology |
- Stock Market
- Insiders
- David D. McMasters